VanEck Associates’s Argan AGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18M Buy
22,584
+8,131
+56% +$5.41M 0.01% 465
2026
Q1
$7.87M Buy
14,453
+508
+4% +$207K 0.01% 658
2025
Q4
$4.37M Buy
+13,945
New +$4.43M ﹤0.01% 829

Other funds holding AGX

VanEck Associates's AGX Position: Q2 2026 in Review

VanEck Associates increased its Argan (AGX) stake by 56% in Q2 2026, buying an estimated $5.41M and bringing the position to 22,584 shares worth $18M. The position accounts for 0.01% of the portfolio, ranked #465.

VanEck Associates first reported a position in AGX in Q4 2025 and has held it in 3 quarters since. 563 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • VanEck Associates held 22,584 shares of Argan worth $18M as of Q2 2026.
  • VanEck Associates bought 8,131 Argan shares in Q2 2026, an estimated $5.41M.
  • Argan made up 0.01% of VanEck Associates's portfolio in Q2 2026, its #465 holding.
  • VanEck Associates first reported a position in Argan in Q4 2025 and has held it in 3 quarters since.
  • 563 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.